University of California, San Diego Medicine 8342, UCSD Medical Center, 200 West Arbor Drive, San Diego, CA 92103, USA.
Nat Rev Nephrol. 2014 Feb;10(2):74-6. doi: 10.1038/nrneph.2013.268. Epub 2013 Dec 24.
In 2013, four important papers were published that provide new insights on biomarkers in acute kidney injury (AKI). These studies demonstrate the potential for biomarkers to aid clinicians in improving the therapeutic management of patients with AKI and potentially improve patient outcomes.
2013 年,发表了四篇重要论文,为急性肾损伤(AKI)的生物标志物提供了新的见解。这些研究表明,生物标志物有可能帮助临床医生改善 AKI 患者的治疗管理,并有可能改善患者的预后。